SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-007289
Filing Date
2015-01-12
Accepted
2015-01-12 08:00:53
Documents
13
Period of Report
2015-01-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850210d8k.htm 8-K 14981
2 EX-99.1 d850210dex991.htm EX-99.1 47492
3 EX-99.2 d850210dex992.htm EX-99.2 21475
4 GRAPHIC g850210ex99_1s1gbgd.jpg GRAPHIC 36857
5 GRAPHIC g850210ex99_1s2gbgd.jpg GRAPHIC 22883
6 GRAPHIC g850210ex99_1s3gbgd.jpg GRAPHIC 37370
7 GRAPHIC g850210ex99_1s4gbgd.jpg GRAPHIC 41597
8 GRAPHIC g850210ex99_1s5gbgd.jpg GRAPHIC 35829
9 GRAPHIC g850210ex99_1s6gbgd.jpg GRAPHIC 47447
10 GRAPHIC g850210ex99_1s7gbgd.jpg GRAPHIC 45964
11 GRAPHIC g850210ex99_1s8gbgd.jpg GRAPHIC 47098
12 GRAPHIC g850210ex99_1s9gbgd.jpg GRAPHIC 22883
13 GRAPHIC g850210gracymabayarhalofenat.jpg GRAPHIC 13423
  Complete submission text file 0001193125-15-007289.txt   570995
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 15520657
SIC: 2834 Pharmaceutical Preparations